The multidrug resistance in human leukemias. Minireview.
Leukemia/lymphoma cells, clinically refractory to therapy are often associated with expression of P-glycoprotein (P-gp), which is encoded by the multidrug resistance (MDR) gene, mdr1. Cell lines expressing mdr1 exhibit resistance to several structurally unrelated lipophilic drugs, such as anthracyclines, vinca alkaloids, and epopodophyllotoxins. This MDR can be conferred to drug-sensitive cells mdr1 cDNA transfer. In resistant cells, MDR is characterized by overexpression of P-gp and by the enhanced efflux, and P-gp fluorescence probe, rhodamine 123 (Rh 123). This can be circumvented by addition of certain non-cytotoxic drugs, such as verapamil and cyclosporin A.
Zubercová
O
O
Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia.
Babusíková
O
O
D000818:Animals; D018432:Drug Resistance, Multiple; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy